Howard Marks and Sohn’s big stars reveal seven rules for investing

Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.

James Thomson

Howard Marks and Sohn’s big stars reveal seven rules for investing

November 15, 2024
Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.
Read Transcript

Trust Howard Marks to deliver the line of the day at the Sohn Hearts & Minds Investment Leaders Conference in Adelaide on Friday, which was abuzz with chat about the prospects for investing under the second Donald Trump administration.

‍What will Trump mean for inflation? What will he mean for growth? What will he mean for geopolitics, and particularly China, which Australia is so reliant on?

‍Howard Marks, co-founder of Oaktree Capital, is prepared to give Trump the benefit of the doubt.  Picture: David Rowe

‍Marks, who declared he was willing to give the second Trump administration the benefit of the doubt, was quick to emphasise that he’s no geopolitical expert.

“Which probably means I’m qualified for a cabinet position,” he quipped.

‍Marks warned Trump “will continue to come out swinging in regards to China” but also predicted that both China and Australia could find ways to navigate the great economic rivalry of our time.

‍China, Marks pointed out, still wants to grow its economy by 5 per cent a year, and there’s simply not enough domestic demand or export demand from countries like Russia, Iran and North Korea to deliver on that goal. “They’re going to have to play by most of the rules and remain part of the world economic community,” Marks said.

Howard Marks, billionaire US investor and Oaktree Capital co-founder. Photo: Ben Searcy

The other big star of the day was Nick Moakes, chief investment officer at the £36.8 billion ($72 billion) Wellcome Trust, which gives a staggering £1.7 billion to medical research each year. He offered a different perspective on China and geopolitics. While the growth of its economy over the last few decades has been staggering, it’s been very hard to make money for the simple fact the economy is hugely competitive, and margins in any given sector are quickly competed away.

But it’s not the only reason he’s wary of investing in China. “We have to worry about the return of our capital as much as the return on our capital,” he said.

Moakes thinks hard about geopolitics, but he also delivered a reminder that should stay at the forefront of investors’ minds as the market ties itself in knots in the coming months trying to second-guess Donald Trump’s next move.

“Ultimately what we are buying is assets, not economies.”

Here are seven big lessons from Moakes and Marks, the stars of the Sohn show on Friday.

Rule number one

Moakes doesn’t like the concept of ESG, which he says has been hijacked by the investment management sector for marketing purposes. But governance explains “rule number one” at the Wellcome Trust. “Don’t invest in anything where the people behind it are, have been, or should be, in prison.”

Easy to say, but sadly not always easy to do.

How to think about returns

‍Moakes comes at investing from a different perspective. His fund has no clients and no time frame – his job is to keep earning money that can be given away. Still, the way he thinks about returns is fascinating.

Using 10 years as a proxy time frame for a long-term investment, he considers four things: what’s the reasonable expected return from an investment; what’s the risk of losing all the Trust’s money on a permanent basis; what liquidity is available (recognising Moakes needs more liquidity than other investors because he wants to keep the money flowing to medical research); and what level of control does he have over the asset.

The higher the risk of permanent capital destruction, the lower the level of liquidity on offer, and the less control Moakes has – does he own 100 per cent of the asset or is he just one of many shareholders, as in a public company? – the greater the excess return he will demand. The Trust targets an inflation-adjusted return of about 4 per cent.

Mainly, do nothing

‍Moakes provided a wry lesson about investment frequency. “What I say to my team is: if in doubt, do nothing. And I am usually in doubt.”

Only four or five big decisions in the past 20 years have made a difference to the Wellcome Trust portfolio, and so when a big change of direction or decision does come up, Moakes wants to place a sizeable bet that can actually make a meaningful difference to returns.

Investors, he reminded the 700-strong crowd, are there to take risk.

Cashflow beats everything

‍Local investing legend Peter Cooper, who interviewed Marks on stage with Chanticleer, probed the Wall Street titan about his thoughts on one of the year’s hottest asset classes: gold. Suffice to say, Marks isn’t a fan.

“If an asset produces cash – a company, a building, a stock, a bond, et cetera – you can assign an intrinsic value to it. But it doesn’t produce cash flow – oil, furs, diamonds, art, crypto and may I say, gold – I think you can’t calculate an intrinsic value, and so investing in it approaches what I would call speculation.”

Moakes didn’t comment on gold, but he takes a similar view of the importance of cash flow.

“The single most important thing is that you need to be invested in real assets … that means you want to own equities of any flavour,” he said. That includes everything from public and private equities to venture capital.

It’s still very hard to beat the US

Many of those equities, Moakes says, continue to be found in the US. His view is that innovation equals productivity, which in turn equals outsized returns. “If you’re going to be investing across the spectrum of venture capital, buy-out funds, all the way through to public equities, you’re naturally going to end up going to the US.”

Marks has a similar view. The US has the world’s greatest mix of “free markets, economic dynamism, creativity, rule of law, personal freedoms [and] deep capital markets” and will probably stay that way. But with valuations historically stretched, Marks did remind the audience “you’re not getting that excellence for nothing”.

Look for the G-TOOT

‍Around the offices of the Wellcome Trust, they like to talk about G-TOOTs – the Greatest Trades of our Time.

Moakes has done two of them, he reckons: in 2018 and 2021, the Wellcome Trust issued bonds at extremely low coupon rates (2.57 per cent and 1.50 per cent) for 100 years and 50 years respectively. Moakes estimates the former deal, where the Trust raised £750 million, could create £20 billion of value if it can achieve that targeted real return of 4 per cent over the next century.

We’re not going back

‍Moakes and Marks were in furious agreement about where inflation and interest rates are heading. The idea that rates are heading back towards 2 per cent, Moakes says, is “bullshit, in my view”.

Marks, who says we may actually be done for US interest rate cuts in the short term given the strength of the economy, expects long-term interest rates to hover around the 3 per cent range. “What that means is that investors in what we call credit or debt or fixed income will be able to achieve good, healthy returns from debt, dependably.”

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Trust Howard Marks to deliver the line of the day at the Sohn Hearts & Minds Investment Leaders Conference in Adelaide on Friday, which was abuzz with chat about the prospects for investing under the second Donald Trump administration.

‍What will Trump mean for inflation? What will he mean for growth? What will he mean for geopolitics, and particularly China, which Australia is so reliant on?

‍Howard Marks, co-founder of Oaktree Capital, is prepared to give Trump the benefit of the doubt.  Picture: David Rowe

‍Marks, who declared he was willing to give the second Trump administration the benefit of the doubt, was quick to emphasise that he’s no geopolitical expert.

“Which probably means I’m qualified for a cabinet position,” he quipped.

‍Marks warned Trump “will continue to come out swinging in regards to China” but also predicted that both China and Australia could find ways to navigate the great economic rivalry of our time.

‍China, Marks pointed out, still wants to grow its economy by 5 per cent a year, and there’s simply not enough domestic demand or export demand from countries like Russia, Iran and North Korea to deliver on that goal. “They’re going to have to play by most of the rules and remain part of the world economic community,” Marks said.

Howard Marks, billionaire US investor and Oaktree Capital co-founder. Photo: Ben Searcy

The other big star of the day was Nick Moakes, chief investment officer at the £36.8 billion ($72 billion) Wellcome Trust, which gives a staggering £1.7 billion to medical research each year. He offered a different perspective on China and geopolitics. While the growth of its economy over the last few decades has been staggering, it’s been very hard to make money for the simple fact the economy is hugely competitive, and margins in any given sector are quickly competed away.

But it’s not the only reason he’s wary of investing in China. “We have to worry about the return of our capital as much as the return on our capital,” he said.

Moakes thinks hard about geopolitics, but he also delivered a reminder that should stay at the forefront of investors’ minds as the market ties itself in knots in the coming months trying to second-guess Donald Trump’s next move.

“Ultimately what we are buying is assets, not economies.”

Here are seven big lessons from Moakes and Marks, the stars of the Sohn show on Friday.

Rule number one

Moakes doesn’t like the concept of ESG, which he says has been hijacked by the investment management sector for marketing purposes. But governance explains “rule number one” at the Wellcome Trust. “Don’t invest in anything where the people behind it are, have been, or should be, in prison.”

Easy to say, but sadly not always easy to do.

How to think about returns

‍Moakes comes at investing from a different perspective. His fund has no clients and no time frame – his job is to keep earning money that can be given away. Still, the way he thinks about returns is fascinating.

Using 10 years as a proxy time frame for a long-term investment, he considers four things: what’s the reasonable expected return from an investment; what’s the risk of losing all the Trust’s money on a permanent basis; what liquidity is available (recognising Moakes needs more liquidity than other investors because he wants to keep the money flowing to medical research); and what level of control does he have over the asset.

The higher the risk of permanent capital destruction, the lower the level of liquidity on offer, and the less control Moakes has – does he own 100 per cent of the asset or is he just one of many shareholders, as in a public company? – the greater the excess return he will demand. The Trust targets an inflation-adjusted return of about 4 per cent.

Mainly, do nothing

‍Moakes provided a wry lesson about investment frequency. “What I say to my team is: if in doubt, do nothing. And I am usually in doubt.”

Only four or five big decisions in the past 20 years have made a difference to the Wellcome Trust portfolio, and so when a big change of direction or decision does come up, Moakes wants to place a sizeable bet that can actually make a meaningful difference to returns.

Investors, he reminded the 700-strong crowd, are there to take risk.

Cashflow beats everything

‍Local investing legend Peter Cooper, who interviewed Marks on stage with Chanticleer, probed the Wall Street titan about his thoughts on one of the year’s hottest asset classes: gold. Suffice to say, Marks isn’t a fan.

“If an asset produces cash – a company, a building, a stock, a bond, et cetera – you can assign an intrinsic value to it. But it doesn’t produce cash flow – oil, furs, diamonds, art, crypto and may I say, gold – I think you can’t calculate an intrinsic value, and so investing in it approaches what I would call speculation.”

Moakes didn’t comment on gold, but he takes a similar view of the importance of cash flow.

“The single most important thing is that you need to be invested in real assets … that means you want to own equities of any flavour,” he said. That includes everything from public and private equities to venture capital.

It’s still very hard to beat the US

Many of those equities, Moakes says, continue to be found in the US. His view is that innovation equals productivity, which in turn equals outsized returns. “If you’re going to be investing across the spectrum of venture capital, buy-out funds, all the way through to public equities, you’re naturally going to end up going to the US.”

Marks has a similar view. The US has the world’s greatest mix of “free markets, economic dynamism, creativity, rule of law, personal freedoms [and] deep capital markets” and will probably stay that way. But with valuations historically stretched, Marks did remind the audience “you’re not getting that excellence for nothing”.

Look for the G-TOOT

‍Around the offices of the Wellcome Trust, they like to talk about G-TOOTs – the Greatest Trades of our Time.

Moakes has done two of them, he reckons: in 2018 and 2021, the Wellcome Trust issued bonds at extremely low coupon rates (2.57 per cent and 1.50 per cent) for 100 years and 50 years respectively. Moakes estimates the former deal, where the Trust raised £750 million, could create £20 billion of value if it can achieve that targeted real return of 4 per cent over the next century.

We’re not going back

‍Moakes and Marks were in furious agreement about where inflation and interest rates are heading. The idea that rates are heading back towards 2 per cent, Moakes says, is “bullshit, in my view”.

Marks, who says we may actually be done for US interest rate cuts in the short term given the strength of the economy, expects long-term interest rates to hover around the 3 per cent range. “What that means is that investors in what we call credit or debt or fixed income will be able to achieve good, healthy returns from debt, dependably.”

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on Nov 15, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
March 14, 2025

$1.4 million boost for SA medical research

South Australian medical research will receive a $1.4 million cash injection, as a direct result of a major investment and philanthropy conference held in Adelaide.

Read More
Anthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. AP
May 19, 2025

Why ‘The Mooch’ thinks Trump is more dangerous this time around

Anthony Scaramucci says Trump has fewer constraints on his worst instincts in his second administration. But he still gets bored easily.

Read More
Image caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn Licht
May 19, 2025

My biggest mistake: Anthony Scaramucci on what makes Donald Trump tick

On Elon Musk, money and the White House, fast-talking Wall Street hedge fund manager and former Trump communications director Anthony Scaramucci tells it as he sees it.

Read More
A bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFP
May 19, 2025

Bitcoin ‘on track’ for $US200,000: Anthony Scaramucci

Bitcoin could hit as much as $US200,000 ($311,000) by the end of this year, fuelled by surging inflows into exchange-traded funds and Donald Trump’s erratic policymaking.

Read More
Anthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn Licht
May 19, 2025

‘The Mooch’ says Trump will have to cut China tariffs below 10pc

Scaramucci, who is best known as The Mooch, is the first big-name global investor to be confirmed for the Sohn Hearts & Minds conference in Sydney in November.

Read More
Matthew McLennan in his office at First Eagle Investments in New York. Picture: Jaclyn LichtMatthew McLennan in his office at First Eagle Investments in New York. Picture: Jaclyn LichtMatthew McLennan in his office at First Eagle Investments in New York. Picture: Jaclyn LichtMatthew McLennan in his office at First Eagle Investments in New York. Picture: Jaclyn Licht
July 7, 2025

A golden year for Wall Street’s Australian stock picker

Matthew McLennan’s $14.5 billion position in gold bars and miners paid off handsomely for First Eagle this year. But he insists the precious metal still has room to run.

Read More
Stillpoint Investments founder and chief investment officer Eric Wong. Picture: Jaclyn LichtStillpoint Investments founder and chief investment officer Eric Wong. Picture: Jaclyn LichtStillpoint Investments founder and chief investment officer Eric Wong. Picture: Jaclyn LichtStillpoint Investments founder and chief investment officer Eric Wong. Picture: Jaclyn Licht
September 25, 2025

Stillpoint founder Eric Wong reveals major China tech investment strategy

Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14.

Read More
October 1, 2025

Billionaire hedge fund manager enacts ‘little short’ on the market

Investing veteran Lord Michael Hintze says he’s taking out insurance against expensive debt and equity markets that are being propelled by passive flows.

Read More
October 1, 2025

Hedge fund guru Michael Hintze can't out-trade machines but he can still 'out-invest' them

Billionaire hedge fund manager Michael Hintze says the world is more dangerous than he has ever seen, artificial intelligence is stifling people’s ability to learn and process information.

Read More
Marathon Resource Advisors founder and chief investment officer Robert Mullin in San Francisco.Marathon Resource Advisors founder and chief investment officer Robert Mullin in San Francisco.Marathon Resource Advisors founder and chief investment officer Robert Mullin in San Francisco.Marathon Resource Advisors founder and chief investment officer Robert Mullin in San Francisco.
October 5, 2025

Marathon CIO Robert Mullin reveals why gold stocks are still undervalued

The son of a stockbroker, Mr Mullin has more than 30 years' investing experience and is chief investment officer at Marathon Resource Advisors in San Francisco, a company he founded.

Read More
First Eagle Investments co-head of global value Matthew McLennan. Picture: Jaclyn LichtFirst Eagle Investments co-head of global value Matthew McLennan. Picture: Jaclyn LichtFirst Eagle Investments co-head of global value Matthew McLennan. Picture: Jaclyn LichtFirst Eagle Investments co-head of global value Matthew McLennan. Picture: Jaclyn Licht
October 6, 2025

First Eagle’s Matthew McLennan on the monetary force that could be ‘rocket fuel’ for the Australian dollar

Matthew McLennan, the co-head of the global value team and portfolio manager at the $US161bn ($243bn) First Eagle Investments, stormed the market with a bullish bet on gold.

Read More
October 10, 2025

Anthony Scaramucci’s advice to our PM is to seek his Canadian counterpart’s counsel

Beyond Wall Street, The Mooch is better known for his cutting takes on US politics in the popular podcast The Rest is Politics: US, which he hosts with BBC’s long-term North American correspondent Katty Kay.

Read More
October 19, 2025

Munro Partners' Qiao Ma reveals AI investment strategy

Qiao Ma has a simple test for spotting the investment opportunities that will define the next decade. Take the technology apart and see what’s inside.

Read More
October 21, 2025

Meet the 2025 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share ten new managers for 2025.

Read More
October 31, 2025

The 42pc gain that shows why Sohn is a stock picker’s delight

It turns out you could have outperformed the seemingly unstoppable magnificent seven tech stocks if you simply acted on the 11 stock picks at Sohn last year.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.